Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT01443559
Other study ID # EIXM-XKFPC-20110901
Secondary ID
Status Suspended
Phase Phase 1
First received September 19, 2011
Last updated July 16, 2015
Start date September 2011
Est. completion date December 2015

Study information

Verified date July 2015
Source Xiamen University
Contact n/a
Is FDA regulated No
Health authority China: Ethics Committee
Study type Interventional

Clinical Trial Summary

Acellular porcine cornea is a valid substitution for human cornea because of its similar biological structure, corneal superficial curvature and good histocompatibility toward human. Facing the lack of human cornea donor, it is hypothesised that using acellular lamellar porcine cornea as an alternative of lamellar human cornea to treat infectious corneal ulcer.


Description:

Acellular porcine cornea eligibility criteria:

1. fresh porcine cornea,

2. porcine cornea keeping transparent without scar, neovascularization or corneal ulcer,

3. porcine cornea keeping integrative corneal epithelium and endothelium,

4. acellular porcine cornea keeping transparent.


Recruitment information / eligibility

Status Suspended
Enrollment 20
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Patients with severe infectious corneal ulcer

- The ulcers can not be controlled with existing antibiotics eye drops or medicine after 1 week treatment

- The infected corneas have risks of penetrating

- The depth of ulcers are less than 400um

- The bridge of the ulcers is away from corneal limbal more than 1mm

- Patients aged 18 or older

- Patients able and willing to sign the informed consent form

Exclusion Criteria:

- Patients with severe infectious corneal ulcer in stable stage

- Patients with corneal ulcers after viruses infection, such as herpes simplex virus

- Patients with corneal ulcers from non-infectious factors, such as toxicity, burn or immunological inflammation

- The ulcers are not cover pupil zone and will not result in visional defect in future

- The depth of ulcer is less than 50um

- Patients has history of keratoplasty surgery

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Genetic:
Xenogenic cornea
lamellar acellular xenogenic corneas were sterilised by radiation
homogenic cornea
homogenic corneas were sterilised by radiation

Locations

Country Name City State
China Xiamen University Affiliated Xiamen Eye Center Xiamen Fujian

Sponsors (1)

Lead Sponsor Collaborator
Xiamen University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of rejection in three months after keratoplasty Rate of epithelium rejection Epithelial rejection performances: 1.1 epithelium edema, OR 1.2 epithelium opacity, OR 1.3 epithelial rejection line.
Rate of stroma rejection Stroma rejection performances: 2.1 stroma edema, OR 2.2 stroma opacity, OR 2.3 suture loosing.
three months after lamellar keratoplasty Yes
Secondary Density of regenerative sub-epithelial nerve plex, stromal nerve and stromal keratocytes in vivo confocal microscopy Shapes and location:
Sub-epithelial nerve plex is in the depth between 35um to 65um shaping like white thin line with branches in vivo confocal microscopy.
Sromal nerve is in the stromal layer(about 70um to 500um) shaping like white thick trunk with branches in vivo confocal microscopy.
Stromal keratocytes is in the stromal layer like white rod-shape in vivo confocal microscopy.
one year Yes